ClinicalTrials.Veeva

Menu
C

Centex Studies | South Houston, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Elagolix
K-877
Testosterone Undecanoate
Nitazoxanide
Filgotinib
Bococizumab
PTI-125
Vilaprisan
Ozanimod
NTZ

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 55 total trials

Study to Evaluate Efficacy, Safety and Tolerability of HM15211(efocipegtrutide) in Subjects

This study is a phase 2 study to Evaluate Efficacy, Safety and Tolerability of HM15211 Treatment for 12 Months in Subjects with Biopsy Confirmed NASH

Enrolling
NASH - Nonalcoholic Steatohepatitis
Drug: HM15211
Drug: Placebo of HM15211

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Enrolling
Lower Respiratory Tract Illness
Biological: RSVpreF
Biological: Placebo

Trial sponsors

Pfizer logo
AbbVie logo
Bayer logo
Boehringer Ingelheim logo
Allergan logo
Astellas logo
C
Celgene logo
G
Kowa logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems